Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teicoplanin versus vancomycin in ICU patients after cardiac surgery
IRCT2016022220592N4Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2012
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of teicoplanin and vancomycin in endocarditis (IE) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Aug 2012; status: completed.
02
Drugs
teicoplaninvancomycin
03
Conditions
endocarditis (IE)
Beyond the preview
Go deeper on IRCT2016022220592N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016022220592N4.